Müller-Ladner, U <br/><br/>
[Are "biologics" in the treatment of rheumatoid arthritis really cost effective?].  [electronic resource] 

 -  Der Internist  Dec 2004 
 - 1402-6 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0020-9554 
<br/><br/><label>Standard No.: </label>10.1007/s00108-004-1297-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--economics<br/>Arthritis, Rheumatoid--economics<br/>Biological Products--economics<br/>Cost-Benefit Analysis--methods<br/>Germany<br/>Health Care Costs<br/>Humans<br/>Quality-Adjusted Life Years<br/>Treatment Outcome